Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis

Published:2021-04-20 Issue:5 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Lee Rose A.¹²,Herigon Joshua C.¹,Benedetti Andrea³,Pollock Nira R.²⁴^ORCID,Denkinger Claudia M.⁵^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts, USA

2. Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

3. Department of Medicine and of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada

4. Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA

5. Division of Clinical Tropical Medicine, Center of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany

Abstract

Nasopharyngeal (NP) swabs are considered the highest-yield sample for diagnostic testing for respiratory viruses, including SARS-CoV-2. The need to increase capacity for SARS-CoV-2 testing in a variety of settings, combined with shortages of sample collection supplies, have motivated a search for alternative sample types with high sensitivity.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02881-20

Reference75 articles.

1. U.S. Food and Drug Administration Center for Devices and Radiological Health. 2020. FAQs on testing for SARS-CoV-2. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/faqs-testing-sars-cov-2. Accessed 12 October 2020.

2. Centers for Disease Control and Prevention. 2020. Information for laboratories about coronavirus (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. Accessed 4 October 2020.

3. Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin

5. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Performance of the BD Respiratory Viral Panel for BD MAX™ System in Detecting SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus;Diagnostic Microbiology and Infectious Disease;2024-11

2. Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis;Journal of Clinical Virology;2024-10

3. A multicenter study to assess the performance of the point-of-care RT-PCR Cobas SARS-2 CoV-2 & Influenza A/B nucleic acid test for use on the Cobas Liat system in comparison with 3 centralized assays across healthcare facilities in the United States;2024-09-06

4. Cross comparison of alternative diagnostic protocols including substitution to the clinical sample, RNA extraction method and nucleic acid amplification technology for COVID-19 diagnosis;Frontiers in Molecular Biosciences;2024-08-23

5. A new strategy of multiplex real-time RT-qPCR assay for differentiating Omicron variants from other SARS-CoV-2 lineages;Biotechnology & Biotechnological Equipment;2024-08-19